#ariba_ref_name	ref_name	gene	var_only	flag	reads	cluster	ref_len	ref_base_assembled	pc_ident	ctg	ctg_len	ctg_cov	known_var	var_type	var_seq_type	known_var_change	has_known_var	ref_ctg_change	ref_ctg_effect	ref_start	ref_end	ref_nt	ctg_start	ctg_end	ctg_nt	smtls_total_depth	smtls_nts	smtls_nts_depth	var_description	free_text
16S.rDNA_WHO_F_01361c	16S.rDNA_WHO_F_01361c	0	1	659	13044	16S	1529	1529	99.87	16S.l15.c4.ctg.1	2259	691.2	0	.	n	.	0	A69G	SNP	69	69	A	294	294	G	829	G,A	601,225	.	.
16S.rDNA_WHO_F_01361c	16S.rDNA_WHO_F_01361c	0	1	659	13044	16S	1529	1529	99.87	16S.l15.c4.ctg.1	2259	691.2	0	.	n	.	0	C1450T	SNP	1450	1450	C	1675	1675	T	807	T,C,G	801,3,3	.	.
16S.rDNA_WHO_F_01361c	16S.rDNA_WHO_F_01361c	0	1	659	13044	16S	1529	1529	99.87	16S.l15.c4.ctg.1	2259	691.2	1	SNP	n	C1184T	0	.	.	1184	1184	C	1409	1409	C	827	C,A	826,1	16S.rDNA_WHO_F_01361c:0:1:C1184T:16S.1184T:E coli C1192T. Resistance to Spectinomycin	.
16S.rDNA_WHO_F_01361c	16S.rDNA_WHO_F_01361c	0	1	659	13044	16S	1529	1529	99.87	16S.l15.c4.ctg.1	2259	691.2	0	HET	.	.	.	G1041A,T	.	1041	1041	G	1266	1266	G	898	G,A,T	662,235,1	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	21764	23S	2890	2890	99.9	23S.l15.c4.ctg.1	4118	659.2	0	.	n	.	0	G1337A	SNP	1337	1337	G	1929	1929	A	913	A	913	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	21764	23S	2890	2890	99.9	23S.l15.c4.ctg.1	4118	659.2	0	.	n	.	0	T1971C	SNP	1971	1971	T	2563	2563	C	726	C,T,A	723,1,1	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	21764	23S	2890	2890	99.9	23S.l15.c4.ctg.1	4118	659.2	1	SNP	n	C2597T	1	C2597T	SNP	2597	2597	C	3189	3189	T	748	T,C,A,G	743,2,1,2	23S.rDNA_WHO_F_01358c:0:1:C2597T:23S.2597T :E coli C2611T. Low-level resistance to Azithromycin	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	21764	23S	2890	2890	99.9	23S.l15.c4.ctg.1	4118	659.2	1	SNP	n	A2045G	0	.	.	2045	2045	A	2637	2637	A	651	A	651	23S.rDNA_WHO_F_01358c:0:1:A2045G:23S.2045G:E coli A2059G. High-level resistance to Azithromycin	.
folP.WHO_G_01367c	folP.WHO_G_01367c	1	1	539	1794	folP	852	852	99.88	folP.l15.c4.ctg.1	2024	110.4	0	.	p	.	0	E151K	NONSYN	451	453	GAA	997	999	AAA	190;189;189	A,C;A;A,G	189,1;189;188,1	.	.
folP.WHO_G_01367c	folP.WHO_G_01367c	1	1	539	1794	folP	852	852	99.88	folP.l15.c4.ctg.1	2024	110.4	1	SNP	p	R228S	1	.	.	682	684	AGC	1228	1230	AGC	184;186;186	A,C;G;C	183,1;186;186	folP.WHO_G_01367c:1:1:R228S:folP.228S:Resistance to sulphonamides	.
gyrA.WHO_F_00668c	gyrA.WHO_F_00668c	1	1	27	4828	gyrA	2751	2751	100.0	gyrA.l15.c4.ctg.1	3890	154.7	1	SNP	p	S91F	0	.	.	271	273	TCC	904	906	TCC	173;175;173	T;C;C	173;175;173	gyrA.WHO_F_00668c:1:1:S91F:gyrA.91F:Resistance to fluoroquinolones	.
gyrA.WHO_F_00668c	gyrA.WHO_F_00668c	1	1	27	4828	gyrA	2751	2751	100.0	gyrA.l15.c4.ctg.1	3890	154.7	1	SNP	p	D95G	0	.	.	283	285	GAC	916	918	GAC	180;181;180	G;A;C	180;181;180	gyrA.WHO_F_00668c:1:1:D95G:gyrA.95G:Resistance to fluoroquinolones	.
gyrA.WHO_F_00668c	gyrA.WHO_F_00668c	1	1	27	4828	gyrA	2751	2751	100.0	gyrA.l15.c4.ctg.1	3890	154.7	1	SNP	p	D95N	0	.	.	283	285	GAC	916	918	GAC	180;181;180	G;A;C	180;181;180	gyrA.WHO_F_00668c:1:1:D95N:gyrA.95N:Resistance to fluoroquinolones	.
mtrR.WHO_X_01389	mtrR.WHO_X_01389	1	1	27	1708	mtrR	633	633	100.0	mtrR.l15.c17.ctg.1	1754	121.2	1	SNP	p	G45D	0	.	.	133	135	GGC	671	673	GGC	193;195;195	G;G;C	193;195;195	mtrR.WHO_X_01389:1:1:G45D:mtrR.45D:Increased efflux of antimicrobials, e.g. macrolides and b-lactam antimicrobials, that are substrates of the MtrCDE efflux pump	.
mtrR_promoter.WHO_F	mtrR_promoter.WHO_F	0	0	531	954	mtrR_promoter	250	250	99.6	mtrR_promoter.l15.c17.ctg.1	1436	82.7	0	.	n	.	0	A197.	DEL	197	197	A	836	836	A	192	A,C	191,1	.	.
parC.WHO_M_00204c	parC.WHO_M_00204c	1	1	27	4516	parC	2304	2304	99.91	parC.l15.c4.ctg.1	3456	163.0	1	SNP	p	D86N	0	.	.	256	258	GAC	799	801	GAC	197;198;198	G;A,C;C	197;197,1;198	parC.WHO_M_00204c:1:1:D86N:parC.86N:Resistance to fluoroquinolones	.
parC.WHO_M_00204c	parC.WHO_M_00204c	1	1	27	4516	parC	2304	2304	99.91	parC.l15.c4.ctg.1	3456	163.0	1	SNP	p	S87W	0	.	.	259	261	AGT	802	804	AGT	196;196;197	A,C;G;T	195,1;196;197	parC.WHO_M_00204c:1:1:S87W:parC.87W:Resistance to fluoroquinolones	.
parC.WHO_M_00204c	parC.WHO_M_00204c	1	1	27	4516	parC	2304	2304	99.91	parC.l15.c4.ctg.1	3456	163.0	1	SNP	p	S87I	0	.	.	259	261	AGT	802	804	AGT	196;196;197	A,C;G;T	195,1;196;197	parC.WHO_M_00204c:1:1:S87I:parC.87I:Resistance to fluoroquinolones	.
parC.WHO_M_00204c	parC.WHO_M_00204c	1	1	27	4516	parC	2304	2304	99.91	parC.l15.c4.ctg.1	3456	163.0	1	SNP	p	S87R	0	.	.	259	261	AGT	802	804	AGT	196;196;197	A,C;G;T	195,1;196;197	parC.WHO_M_00204c:1:1:S87R:parC.87R:Resistance to fluoroquinolones	.
parC.WHO_M_00204c	parC.WHO_M_00204c	1	1	27	4516	parC	2304	2304	99.91	parC.l15.c4.ctg.1	3456	163.0	1	SNP	p	S88P	0	.	.	262	264	TCC	805	807	TCC	198;202;204	T,G;C;C	197,1;202;204	parC.WHO_M_00204c:1:1:S88P:parC.88P:Resistance to fluoroquinolones	.
parE.WHO_F_01528c	parE.WHO_F_01528c	1	1	27	3556	parE	1986	1986	100.0	parE.l15.c4.ctg.1	3079	144.1	1	SNP	p	G410V	0	.	.	1228	1230	GGC	1776	1778	GGC	197;195;193	G,T;G;C	196,1;195;193	parE.WHO_F_01528c:1:1:G410V:parE.410V:Resistance to fluoroquinolones	.
penA.9.001	penA.9.001	1	1	539	3454	penA	1749	1749	99.94	penA.l15.c4.ctg.1	2920	147.5	0	.	p	.	0	K8E	NONSYN	22	24	AAG	545	547	GAG	131;133;135	G;A;G	131;133;135	.	.
penA.9.001	penA.9.001	1	1	539	3454	penA	1749	1749	99.94	penA.l15.c4.ctg.1	2920	147.5	1	SNP	p	A311V	0	.	.	931	933	GCA	1454	1456	GCA	227;227;229	G,A;C;A,C	226,1;227;227,2	penA.9.001:1:1:A311V:penA.311V:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.9.001	penA.9.001	1	1	539	3454	penA	1749	1749	99.94	penA.l15.c4.ctg.1	2920	147.5	1	SNP	p	I312M	0	.	.	934	936	ATC	1457	1459	ATC	230;228;229	A,G;T;C,A	229,1;228;227,1	penA.9.001:1:1:I312M:penA.312M:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.9.001	penA.9.001	1	1	539	3454	penA	1749	1749	99.94	penA.l15.c4.ctg.1	2920	147.5	1	SNP	p	V316P	0	.	.	946	948	GTG	1469	1471	GTG	224;225;225	G,T;T,G;G,T	223,1;224,1;224,1	penA.9.001:1:1:V316P:penA.316P:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.9.001	penA.9.001	1	1	539	3454	penA	1749	1749	99.94	penA.l15.c4.ctg.1	2920	147.5	1	SNP	p	V316T	0	.	.	946	948	GTG	1469	1471	GTG	224;225;225	G,T;T,G;G,T	223,1;224,1;224,1	penA.9.001:1:1:V316T:penA.316T:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.9.001	penA.9.001	1	1	539	3454	penA	1749	1749	99.94	penA.l15.c4.ctg.1	2920	147.5	1	SNP	p	T484S	0	.	.	1450	1452	ACC	1973	1975	ACC	165;167;166	A;C;C	165;167;166	penA.9.001:1:1:T484S:penA.483S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.9.001	penA.9.001	1	1	539	3454	penA	1749	1749	99.94	penA.l15.c4.ctg.1	2920	147.5	1	SNP	p	A502V	0	.	.	1504	1506	GCG	2027	2029	GCG	162;162;166	G,T;C,T;G	161,1;161,1;166	penA.9.001:1:1:A502V:penA.501V:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.9.001	penA.9.001	1	1	539	3454	penA	1749	1749	99.94	penA.l15.c4.ctg.1	2920	147.5	1	SNP	p	A502P	0	.	.	1504	1506	GCG	2027	2029	GCG	162;162;166	G,T;C,T;G	161,1;161,1;166	penA.9.001:1:1:A502P:penA.501P:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.9.001	penA.9.001	1	1	539	3454	penA	1749	1749	99.94	penA.l15.c4.ctg.1	2920	147.5	1	SNP	p	G543S	0	.	.	1627	1629	GGC	2150	2152	GGC	201;197;198	G,C;G;C	200,1;197;198	penA.9.001:1:1:G543S:penA.542S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.9.001	penA.9.001	1	1	539	3454	penA	1749	1749	99.94	penA.l15.c4.ctg.1	2920	147.5	1	SNP	p	G546S	0	.	.	1636	1638	GGC	2159	2161	GGC	200;199;200	G,C,A;G,C;C	198,1,1;198,1;200	penA.9.001:1:1:G546S:penA.545S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.9.001	penA.9.001	1	1	539	3454	penA	1749	1749	99.94	penA.l15.c4.ctg.1	2920	147.5	1	SNP	p	L552S	0	.	.	1654	1656	CTG	2177	2179	CTG	207;207;205	C,A;T,G;G,T	206,1;206,1;204,1	penA.9.001:1:1:L552S:penA.551S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
ponA.WHO_G_00106	ponA.WHO_G_00106	1	1	27	4960	ponA	2397	2397	100.0	ponA.l15.c4.ctg.1	3661	169.0	1	SNP	p	L421P	1	.	.	1261	1263	CCG	1967	1969	CCG	176;177;179	C,A;C,A;G	175,1;176,1;179	ponA.WHO_G_00106:1:1:L421P:ponA.421P:High-level chromosomally-mediated penicillin resistance	.
porA.NCCP11945	porA.NCCP11945	1	0	531	4018	porA	1146	1146	99.65	porA.l6.c30.ctg.1	2263	221.2	0	.	p	.	0	M83fs	FSHIFT	247	247	A	843	843	C	264	C,T	263,1	.	.
porB1a.WHO_F_02106	porB1a.WHO_F_02106	1	0	512	256	porB1a	984	156	92.95	porB1a.l15.c17.ctg.4	156	44.9	0	.	p	.	0	V258L	NONSYN	772	774	GTA	14	16	TTA	25;28;29	T;T;A	25;28;29	.	.
porB1a.WHO_F_02106	porB1a.WHO_F_02106	1	0	512	256	porB1a	984	156	92.95	porB1a.l15.c17.ctg.4	156	44.9	0	.	p	.	0	Y273H	NONSYN	817	819	TAT	59	61	CAT	56;56;56	C;A;T	56;56;56	.	.
porB1a.WHO_F_02106	porB1a.WHO_F_02106	1	0	512	256	porB1a	984	156	92.95	porB1a.l15.c17.ctg.4	156	44.9	0	.	p	.	0	D274S	NONSYN	820	822	GAT	62	64	AGT	56;56;56	A;G;T	56;56;56	.	.
porB1a.WHO_F_02106	porB1a.WHO_F_02106	1	0	512	256	porB1a	984	156	92.95	porB1a.l15.c17.ctg.4	156	44.9	0	.	p	.	0	N277Y	NONSYN	829	831	AAC	71	73	TAC	56;56;56	T;A;C	56;56;56	.	.
porB1a.WHO_F_02106	porB1a.WHO_F_02106	1	0	512	256	porB1a	984	90	95.56	porB1a.l15.c17.ctg.5	166	42.7	0	.	p	.	0	M18T	NONSYN	52	54	ATG	128	130	ACG	47;42;42	A;C;G	47;42;42	.	.
porB1b.WHO_V_02265c	porB1b.WHO_V_02265c	1	1	539	2692	porB1b	1047	1047	99.24	porB1b.l15.c17.ctg.1	1962	170.7	0	.	p	.	0	N38E	NONSYN	112	114	AAT	654	656	GAA	249;249;250	G;A,G,C;A	249;244,3,2;250	.	.
porB1b.WHO_V_02265c	porB1b.WHO_V_02265c	1	1	539	2692	porB1b	1047	1047	99.24	porB1b.l15.c17.ctg.1	1962	170.7	0	.	p	.	0	N134D	NONSYN	400	402	AAT	942	944	GAT	227;227;226	G,A;A;T	225,1;226;225	.	.
porB1b.WHO_V_02265c	porB1b.WHO_V_02265c	1	1	539	2692	porB1b	1047	1047	99.24	porB1b.l15.c17.ctg.1	1962	170.7	0	.	p	.	0	P175S	NONSYN	523	525	CCA	1065	1067	TCA	235;234;233	T;C,A;A	235;233,1;233	.	.
porB1b.WHO_V_02265c	porB1b.WHO_V_02265c	1	1	539	2692	porB1b	1047	1047	99.24	porB1b.l15.c17.ctg.1	1962	170.7	0	.	p	.	0	A218V	NONSYN	652	654	GCC	1194	1196	GTC	212;211;209	G,A;T,C;C,G,A	211,1;210,1;207,1,1	.	.
porB1b.WHO_V_02265c	porB1b.WHO_V_02265c	1	1	539	2692	porB1b	1047	1047	99.24	porB1b.l15.c17.ctg.1	1962	170.7	0	.	p	.	0	F222S	NONSYN	664	666	TTT	1206	1208	TCT	197;200;202	T;C,T;T	197;199,1;202	.	.
porB1b.WHO_V_02265c	porB1b.WHO_V_02265c	1	1	539	2692	porB1b	1047	1047	99.24	porB1b.l15.c17.ctg.1	1962	170.7	0	.	p	.	0	E328A	NONSYN	982	984	GAA	1524	1526	GCA	188;189;189	G;C,A;A,C	188;187,2;188,1	.	.
porB1b.WHO_V_02265c	porB1b.WHO_V_02265c	1	1	539	2692	porB1b	1047	1047	99.24	porB1b.l15.c17.ctg.1	1962	170.7	1	SNP	p	G120K	1	.	.	358	360	AAG	900	902	AAG	215;220;217	A;A;G	215;220;217	porB1b.WHO_V_02265c:1:1:G120K:porB1b.120K:G101K. Mediates decreased permeability of antimicrobials through the porin PorB1b	.
porB1b.WHO_V_02265c	porB1b.WHO_V_02265c	1	1	539	2692	porB1b	1047	1047	99.24	porB1b.l15.c17.ctg.1	1962	170.7	1	SNP	p	A121D	1	.	.	361	363	GAC	903	905	GAC	218;220;222	G,A;A,T;C	217,1;219,1;222	porB1b.WHO_V_02265c:1:1:A121D:porB1b.121D:A102D. Mediates decreased permeability of antimicrobials through the porin PorB1b	.
porB1b.WHO_V_02265c	porB1b.WHO_V_02265c	1	1	539	2692	porB1b	1047	1047	99.24	porB1b.l15.c17.ctg.1	1962	170.7	1	SNP	p	D121N	0	.	.	361	363	GAC	903	905	GAC	218;220;222	G,A;A,T;C	217,1;219,1;222	porB1b.WHO_V_02265c:1:1:D121N:porB1b.121N:A102N. Mediates decreased permeability of antimicrobials through the porin PorB1b	.
rpoB.WHO_F_02153c	rpoB.WHO_F_02153c	1	1	539	9000	rpoB	4179	4179	99.98	rpoB.l15.c4.ctg.1	5505	203.9	1	SNP	p	H553N	1	H553N	NONSYN	1657	1659	CAT	2314	2316	AAT	192;192;194	A;A,G;T,G	192;191,1;193,1	rpoB.WHO_F_02153c:1:1:H553N:rpoB.553N:H552N. High-level resistance to Rifampicin	.
rpsJ.WHO_Y_02241	rpsJ.WHO_Y_02241	1	1	27	1354	rpsJ	312	312	100.0	rpsJ.l15.c4.ctg.1	1536	109.8	1	SNP	p	V57M	1	.	.	169	171	ATG	721	723	ATG	229;230;231	A;T;G	229;230;231	rpsJ.WHO_Y_02241:1:1:V57M:rpsJ.57M:Chromosomally-mediated resistance to tetracyclines	.
